| Financial Year |
March 31 2023 |
| Monetary Funds |
1,465,942,770.20 |
| Held-for-trading Financial Assets |
546,157,828.67 |
| Notes Receivable |
431,336,881.39 |
| Accounts Receivable |
756,405,866.92 |
| Advances to Suppliers |
125,247,007.19 |
| Other Receivables |
16,612,264.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
425,645,340.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
125,945,859.01 |
| Total Current Assets |
4,209,652,513.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
192,816,313.98 |
| Investment Properties |
-- |
| Fixed Assetes |
2,640,548,123.42 |
| Under-construction Projects |
1,652,651,597.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
369,983,079.83 |
| R&D expenses |
-- |
| Goodwill |
2,056,577.61 |
| Long-Term Deferred and Prepaid Expenses |
2,636,316.67 |
| Deferred Income Tax Assets |
54,330,593.91 |
| Other Non-Current Assets |
377,249,796.74 |
| Sub-Total of Non-Current Assets |
5,300,717,335.60 |
| Total Assets |
9,510,369,849.17 |
| Short-Term Loans |
1,053,660,657.70 |
| Trading Financial liabilities |
-- |
| Notes Payable |
260,728,949.31 |
| Accounts Payable |
461,452,820.37 |
| Accounts Received In Advance |
7,000,000.00 |
| Employee Compensation Payable |
24,847,359.29 |
| Taxes Payable |
17,895,736.98 |
| Interest Payable |
-- |
| Dividend Payable |
436,749.96 |
| Other payables |
194,428,908.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
458,085,111.82 |
| Other Current Liabilities |
287,404,633.43 |
| Sub-Total of Current Liabilities |
2,796,821,984.66 |
| Long-term Loans |
790,846,549.72 |
| Bonds Payable |
1,177,236,238.31 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
10,824,896.75 |
| Deferred Income Tax Liabilities |
2,353,183.87 |
| Other Non-Current Liabilities |
19,181,470.92 |
| Sub-Total of Non-Current Liabilities |
2,254,992,714.00 |
| Total Liabilities |
5,051,814,698.66 |
| Paid-In Capital(Or Share Stock) |
916,515,612.00 |
| Capital Surplus |
1,939,294,949.16 |
| Surplus Reserve |
162,159,541.87 |
| LESS:Treasury Stock |
153,645,728.04 |
| Undistributed Profits |
1,213,231,931.77 |
| Minority Stockholder's Interest |
156,414,946.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,302,140,203.76 |
| Owner's Equity（Stockholder's Equity） |
4,458,555,150.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,510,369,849.17 |
